Medline Inc. 8-K

What Happened

• On May 6, 2026, Medline Inc. (MDLN) filed a Current Report on Form 8‑K under Item 2.02 (Results of Operations and Financial Condition) to furnish an earnings press release announcing results for the quarter ended March 28, 2026.
• The press release is furnished as Exhibit 99.1; the filing also includes the Inline XBRL cover page as Exhibit 104. The report is signed by Jessi L. Corcoran, Chief Accounting Officer, dated May 6, 2026.

Key Details

• Filing date: May 6, 2026.
• Reporting period: Quarter ended March 28, 2026.
• Exhibit 99.1: Medline Inc. press release with the Q1 results; Exhibit 104: Inline XBRL cover page.
• The 8‑K furnishes the press release; it does not separately amend financial statements or report other corporate actions (e.g., executive changes or mergers).

Why It Matters

• This filing makes Medline’s Q1 2026 quarterly results publicly available; investors should review the press release (Exhibit 99.1) for revenue, profit/loss, cash flow, and any commentary on outlook or guidance.
• The 8‑K itself is a notice that the company has released its quarterly performance — the specific financial figures and management commentary will drive investor decisions and potential market reaction.